CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its molecular diagnostics laboratory has received College of American Pathologists (CAP) accreditation based on a recent on-site inspection as part of CAP’s Accreditation Programs. The CAP accreditation – and the Clinical Laboratory Improvement Amendments (CLIA) certification that CIRCULOGENE achieved in 2015 – are internationally recognized credentials awarded to laboratories complying with the most comprehensive, rigorous and scientifically-endorsed standards of laboratory practice. “This
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a binding offer to acquire Citoxlab for €448 million in cash (or approximately $510 million based on current exchange rates), subject to customary closing adjustments. The proposed transaction is expected to close in the second quarter of 2019, subject to labor consultations, regulatory requirements, and customary closing conditions. Upon completion of the labor consultations, Citoxlab’s shareholders are expected to enter into
RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, today announced the completion of a joint venture partnership agreement with AKESOgen, an industry-leading commercial laboratory facility and provider of clinical trial precision medicine services located in Atlanta, Georgia
SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the Australian 2019 flu season. The test utilises SpeeDx market-leading PlexPCR® multiplex technology, designed for detection of 14 targets representing 10 viral respiratory-illness causing pathogens. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190212006006/en/ SpeeDx PlexPCR RespiVirus offers excellent sensitivity and improved productivity for fast and reproducible respiratory
Instem, a leading provider of IT solutions to the global life sciences market, is pleased to announce that leading research organizations are deploying the Cyto Study Manager software solution to support pioneering regulatory genetox testing techniques. Clients across Europe and North America are using‘MicroFlow®’ micronucleus kits from Litron Laboratories, in conjunction with the Micronucleus Module of Cyto Study Manager. By combining the MicroFlow method with Cyto Study Manager’s experiment set-up and automatic reporting, those
CSI Laboratories, a nationally renowned laboratory specializing in comprehensive cancer diagnostics, recently announced the opening of a new flow cytometry laboratory in Jupiter, Florida
On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted fluorescent dyes to improve cancer surgery, announced today that the protocol for the company's Phase 3 clinical trial, OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer, has been amended to allow the use of Quest Medical Imaging's Spectrum® Platform camera system
Forney LP, the premier supplier of construction material testing equipment, is pleased to announce continuing upgrades to its transformative ForneyVault® technology
In the patient-centric world of radiation oncology, it is critical that CT simulation is accessible, repeatable and flexible. To build on these values, Canon Medical Systems USA, Inc. is now expanding its offerings for CT simulation in radiation oncology to include the Aquilion Prime SP and Aquilion Lightning 80 premium CT systems
Avalon GloboCare Corp. (NASDAQ:AVCO) (NASDAQ listed Avalon GloboCare AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that its ongoing co-development program with Weill Cornell Medicine, led by Yen-Michael Hsu, M.D., Ph.D., Director of cGMP Cellular Therapy Facility and Laboratory for Advanced Cellular Engineering, has identified novel human angiogenic exosomes/extracellular cellular vesicles (EV) derived from endothelial cells
|
|
|
|
|
|
|
|
|